四种吸烟指标对HPV阳性口咽癌诊断后生存的影响
该研究回顾性分析了2012至2019年在本医疗系统内治疗的367例HPV阳性口咽鳞状细胞癌患者,评估四种吸烟指标对3年无复发生存和总生存的影响。结果显示,无任何吸烟指标显著影响3年无复发生存;单因素分析中所有吸烟指标均与较差总生存相关,多因素分析中当前吸烟和曾经吸烟状态显著影响3年总生存。作者认为吸烟对预后的影响可能受队列特异性因素调节。
要点
- 在367例HPV阳性口咽癌患者中,无任何吸烟指标显著影响3年无复发生存。
- 单因素分析中所有吸烟指标均与较差总生存相关。
- 多因素分析中当前吸烟和曾经吸烟状态显著影响3年总生存。
核心结论
- 吸烟对HPV阳性口咽鳞状细胞癌结局的影响并非普遍存在,可能受其他队列特异性因素调节。
- 随着吸烟率下降,吸烟的影响可能减弱。
研究设计与样本
- 回顾性综述,纳入2012至2019年在本医疗系统内治疗的HPV阳性口咽鳞状细胞癌患者,排除转移性疾病或同时性第二原发肿瘤者,共367例符合纳入标准。
- 评估四种吸烟指标:当前/既往/从不吸烟、曾经/从不吸烟、吸烟史>10包年、吸烟史>20包年。
- 主要结局为3年无复发生存和总生存。
主要发现
- 367例患者中,从不吸烟者占37.3%(137/367),诊断时当前吸烟者占13.8%(51/367),既往吸烟者占48.8%(179/367)。
- 无任何吸烟指标显著影响3年无复发生存。
- 单因素分析中,所有吸烟指标均与较差总生存相关。
- 多因素分析中,当前吸烟和曾经吸烟状态显著影响3年总生存。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: While tobacco use is understood to negatively impact HPV+ oropharyngeal squamous cell carcinoma (OPSCC) outcomes, debate remains as to how this impact differs between cohorts. Multiple smoking metrics have been identified as having the greatest prognostic significance, and some recent works have found smoking to have no significant impact. Herein, we show through an analysis of four common smoking metrics that while smoking impacts overall survival (OS), it has a limited impact on recurrence-free survival (RFS) in our cohort. METHODS: We conducted a retrospective review of patients treated for HPV+ OPSCC in our health system from 2012 to 2019. Patients with metastatic disease or concurrent second primaries were excluded. Four metrics of tobacco use were assessed: current/former/never smokers, ever/never smokers, and smokers with >10 or >20 pack-year (PY) smoking histories. Our main outcomes were 3-year RFS and OS. RESULTS: Three hundred and sixty-seven patients met inclusion criteria. 37.3% of patients (137/367) were never-smokers; 13.8% of patients (51/367) were currently smoking at diagnosis and 48.8% of patients (179/367) were former smokers. No tobacco-use metric significantly impacted 3-year RFS. On univariate analysis, all smoking metrics yielded inferior OS. On multivariate analysis, current and ever smoking status significantly impacted 3-year OS. CONCLUSION: The impact of tobacco use on HPV+ OPSCC outcomes is not universal, but may instead be modulated by other cohort-specific factors. The impact of smoking may decrease as rates of tobacco use decline. LEVEL OF EVIDENCE: 3 (Cohort and case-control studies) Laryngoscope, 134:3158-3164, 2024.
引用
- Wilkins SG, Shah R, Safranek CW, et al. The Impact of Four Smoking Metrics on Survival After Diagnosis with HPV+ Oropharyngeal Cancer. Laryngoscope. 2024. PMID: 38294283. doi:10.1002/lary.31319
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。